Anhui Anke Biotechnology (Group) Co Ltd

Overview

Anhui Anke Biotechnology (Group) Co Ltd (Anhui) is a developer, manufacturer and distributor of healthcare and pharmaceutical products. The company’s products portfolio comprise diagnostic products, genetic engineering products, polypeptide APIs, biochemistry products, precision medicine, synthetic medicines, biomedical products, and modern Chinese herb medicines. In addition, it also provides series of recombinant human interferon alpha 2b, recombinant human growth hormone, and MAR kit for anti-sperm antibody. AnkeBio’s products are used in the treatment of leukemia, nutritional support, tumor, chronic hepatitis B, burned wounds and immunopurification sterility, among others. The company also conducts research and development for recombinant drugs, pharmaceutical formulation, immunological and traditional Chinese medicines, and chemical medicine. AnkeBio is headquartered in Hefei, China
Key Stats
Address
K-1 Customs Road, No.669 Changjng Wst Rd, Hi-tech Zone, High-tech Zone, HEFEI, Anhui
Headquarters

China

Contact

86 551 65316659

Website
www.ankebio.com
No of Employees

2,384

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

300009 [SZSE]

Revenue (2020)

$247 m

-0.4% (2020 vs 2019)
Net Income (2020)

$52 m

188.6% (2020 vs 2019)
Net Profit Margin

21 %

190.2% (2020 vs 2019)
Market Cap *

$3,143 m

EPS *

$0

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Anhui Anke Biotechnology (Group) Co LtdSinopharm Accord Pharmaceutical Co LtdJiuzhitang Co LtdTofflon Science & Technology Group Co Ltd
Key Information
Headquarters China China China China
Headquarter City HEFEI SHENZHEN BEIJING SHANGHAI
Headquarter State/Province Anhui Guangdong Beijing Shanghai
No. of Employees 2,384 38,289 4,552 2,661
Entity Type Public Public Public Public

Products & Services

Anhui s one of the largest biopharmaceutical high-tech enterprises in China. Key products offered by the company include the following:

Products
  • Products
  • Recombinant Human Interferon a 2b Eyedrop
  • Recombinant Human Interferon a 2b Cream
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Brands
  • Ansomone
  • Anterferon
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2020 Contracts/Agreements In December, the company signed a strategic cooperation agreement with Jiangsu Jingze Biomedical to supplement…
2017 Plans/Strategy In April, the company planned to sell its Zhejiang-based pharma unit for CNY18.4 million.
2017 Contracts/Agreements In August, the company entered into to agreement to acquire 30% stake in Biotechnology Company…
2016 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2016 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2016 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Anhui Anke Hengyi Pharmaceutical Co., Ltd.

Address

Economic Technology Development Zone, Tongling
China

Telephone

86 562 2655853

Hefei Hankemab Biotechnology Co Ltd

Address

Room 601, Block A, Anke Biology, No. 9, Haiguan Road, High-tech Zone, Hefei
China

Telephone

86 551 65325997

Website

www.hankebio.com
Anhui Anke Yuliangqing Pharmaceutical Co., Ltd.

Address

No.7 Redian Road Anqing,AnhuiAnqing, AnhuiChina
China

Telephone

86 556 5551049

Website

www.akyuliangqing.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
28 Apr 2018 Anhui Anke Biotech Plans to Raise up to USD157 Million in Private Placement of Shares Equity Offering Anhui Anke Biotechnology (Group) Co Ltd
20 Oct 2017 Anhui Anke Biotechnology to Acquire 30% Stake in Hubei-Based Bio-Tech Firm for USD22.64 Million Acquisition Anhui Anke Biotechnology (Group) Co Ltd
09 Aug 2017 Anhui Anke Biotech to Acquire 30% Stake in Biotechnology Company for USD15.6 Million Acquisition Anhui Anke Biotechnology (Group) Co Ltd
27 Apr 2017 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
16 Nov 2016 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
27 Oct 2016 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

7

Active Jobs

0

Posted

0

Closed

Job Trends

Latest Jobs

Job title Company Country
Postdoctoral researcher Anhui Anke Biotechnology (Group) Co Ltd China
Clinical monitor Anhui Anke Biotechnology (Group) Co Ltd China
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar